Statin use and morbidity outcomes in septic shock patients: A retrospective cohort study

Critical Care and Shock

Volumn 14, Issue 1, 2011, Pages 15-18

  Chua, Doson ^a   Choice, Karina ^a   Gellatly, Rochelle ^a   Brown, Glen ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

HMG CoA Reductase inhibitors; Sepsis; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE AGENT;

ADULT; AGED; COHORT ANALYSIS; DRUG USE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; RETROSPECTIVE STUDY; REVIEW; SEPTIC SHOCK; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 79959318260     PISSN: 14107767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.
2. Russell JA. Management of sepsis. N Engl J Med 2006;355:1699-1713.
3. Chua D, Tsang R, Kuo IF. The role of statin therapy in sepsis. Ann Pharmacother 2007;41:647-652.
4. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis 2007;7:358-668. 5.
5. Martin CP, Talbert RL, Burgess DS, Peters JI. Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation. Pharmacotherapy 2007;27:20-26.